Portal de Periódicos da CAPES

A comparative study on glucagon effect between mcardle disease and tarui disease

1984; Wiley; Volume: 7; Issue: 7 Linguagem: Inglês

10.1002/mus.880070706

1097-4598

Ikuo Mineo, Norio Kôno, Takao Shimizu, Seiichi Sumi, Kyohei Nonaka, Seiichiro Tarui,

Cell Adhesion Molecules Research

Abstract Pretreatment with glucagon relieved patients with McArdle disease from muscular symptoms during exercise and enhanced exercise performance, though it did not produce any improvement in patients with Tarui disease. The difference in glucagon effect between the two diseases was clearly demonstrated in the bicycle ergometer exercise tests. In addition, the semi‐ischemic forearm exercise tests performed after glucagon injection showed that increased lactate production was significantly incluced by exercise in McArdle disease, but it was not the case in Tarui disease. In McArdle disese, the augmentation in exercise‐induced lactate production was also observed after administration of glucose, or glucose plus insulin, but it was neither observed after administration of insulin alone nor after arginine or epinephrine administration. These findings suggest that the beneficial effect of glucagon in McArdle disease is due to the enhanced utilization of circulating glucose through the muscular glycolytic pathway realized in the coexistence of hyperglycemia and hyperinsulinemia.